Olema Pharmaceuticals, Inc. OLMA Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s other income (expense)?
- Olema Pharmaceuticals, Inc. (OLMA) reported other income (expense) of $4.9M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Olema Pharmaceuticals, Inc.'s other income (expense) increased by 9.2% year-over-year, from $4.48M to $4.9M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s other income (expense) has grown at a 153.2% compound annual growth rate (CAGR), from $395K to $16.25M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.